BCAB
BioAtla, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.74
+2.66%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.08x
- Price / sales
- 0.34x
- Price / cash flow
- -0.12x
Enterprise value
- Enterprise value
- $7.2M
- EV / sales
- 0.85x
- EV / EBITDA
- -0.25x
- EV / EBIT
- -0.23x
- Market cap
- $2.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026